Airedale NHS Foundation Trust

West Yorkshire and Harrogate, Cancer Alliance

Management of High Grade Dysplasia patients

Time period: 2016-20
Cancer Alliance National
Number of High Grade Dysplasia patients in audit 17 1372
Cancer Alliance National
Method of Diagnosis
– First diagnosis confirmed by second pathologist 15 88.2% 88.1%
Treatment planning
– HGD plan discussed at MDT 17 100.0% 89.7%
– Treatment plan for active treatment 15 86.7% 78.8%
First treatment
– Endoscopic therapy (such as endoscopic resection) 15 86.7% 71.8%
– Surveillance 2 13.3% 13.9%

Management of oesophago-gastric cancer patients

Time period: 2018-2020
Organisation National
Number of oesophago-gastric (OG) cancer patients in audit 68 20,319
Case ascertainment for OG cancer (%) 85-100%
Method of Diagnosis
– Patients diagnosed after an emergency admission**
** Percent figure accounts for differences in mix of patients across organisations
12 21.0% 12.6%
– Patients with referral source reported as unknown 5 7.4% 1.8%
Pre-treatment staging of cancer
– Patients having staging CT scan recorded 65 95.6% 85.9%
Treatment planning
– Patients having a plan for curative treatment 18 26.5% 39.4%
– Patients having a plan for non-curative treatment 50 73.5% 60.6%
– Patients with non-curative plans having chemotherapy or radiotherapy 17 34.0% 42.8%

Download this data as a PDF